Innov17 LLC

Innov88 LLC

Innovimmune Biotherapeutics, Inc.

Gaweco, Anderson

Monahan, Joseph B.

Carroll, Jeffery

Cubbage, Jerry W.

Walker, John

Anderson Gaweco

Jefferson Wright Tilley

James Robert Blinn

John Walker

Samantha Palmer

Joseph B Monahan

Jeffery N Carroll

Jerry W Cubbage

Jeffery Carroll

Provided herein are compounds of the formulas (I) and (II): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of Retinoic Acid Receptor-Related Orphan Receptor regulated diseases and disorders.

Indazole retinoic acid receptor-related orphan receptor modulators and uses thereof

Provided herein are compounds of the formulas (I) and (II): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of Retinoic Acid Receptor-Related Orphan Receptor regulated diseases and disorders.  

Benzimidazole retinoic acid receptor-related orphan receptor modulators and uses thereof

The invention relates to ROR modulators; compositions comprising an effective amount of a ROR modulator; and methods for treating or preventing diseases associated with ROR.

ROR modulators and their uses

Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of Retinoic Acid Receptor-Related Orphan Receptor regulated diseases and disorders.

Sulfonamide retinoic acid receptor-related orphan receptor modulators and uses thereof

The invention relates to ROR modulators; compositions comprising an effective amount of a ROR modulator; and methods for treating or preventing diseases associated with ROR. The invention is based in part on the discovery of ROR modulators which interact with RORa and/or RORy and thereby inhibit or induce RORa and/or RORy-activity, and RORa- and/or RORy-regulated target gene and protein expression.

The invention relates to MIF inhibitors; compositions comprising an effective amount of a MIF inhibitor; and methods for treating or preventing diseases associated with MIF.

Growing community of inventors

Brooklyn, NY, United States of America

Anderson Gaweco